Department of Surgical Sciences, Laboratory of Cerebrovascular Research, Anesthesiology & Intensive Care medicine, University Hospital, Uppsala University, SE-75185 Uppsala, Sweden.
Expert Rev Neurother. 2013 Oct;13(10):1085-8. doi: 10.1586/14737175.2013.836297. Epub 2013 Oct 3.
The 10th Global College of Neuroprotection and Neuroregeneration Annual Conference in collaboration with the 6th International Association of Neurorestoratology VI Intercontinental Hotel, Bucharest, Romania, 4-7 April 2013 The 10th Global College of Neuroproetction and Neuroregeneration Annual Conference together with the International Association of Neurorestoratology VI was held in Bucharest under the auspicious of the Society for the Study of Neuroprotection and Neuroplasticity during 4-7 April 2013. The focus of these unified societies meeting was on neurorestoration, neuroprotection and neuroregeneration in various clinical neurodegenerative diseases; for example, Alzheimer's, Parkinson's, Huntington's disease, stroke and brain or spinal cord injuries. The main aim to enhance healthcare was suggested by the use of stem cells, nanodrug delivery of drugs and stem cells, use of multimodal drugs as well as a combination of different approaches. The meeting was attended by more than 500 delegates including researches, policy makers and healthcare professionals along with several representatives from drug industries from Europe and USA. It appears that future of neuroprotection could be achieved by the use of stem cells and nanodrug delivery in chronic neurological disorders.
2013 年 4 月 4 日至 7 日,罗马尼亚布加勒斯特 VI 洲际酒店,第 10 届全球神经保护和神经再生学院年会与第六届国际神经修复学会联合举办。第 10 届全球神经保护和神经再生学院年会与国际神经修复学会联合举办,在神经保护和神经可塑性学会的支持下于 2013 年 4 月 4 日至 7 日在布加勒斯特举行。这些联合协会会议的重点是各种临床神经退行性疾病中的神经修复、神经保护和神经再生,例如阿尔茨海默病、帕金森病、亨廷顿病、中风以及脑或脊髓损伤。通过使用干细胞、药物和干细胞的纳米药物输送、使用多模态药物以及结合不同方法,提出了增强医疗保健的主要目标。来自欧洲和美国的药物行业的几位代表以及 500 多名代表参加了会议,包括研究人员、政策制定者和医疗保健专业人员。似乎通过在慢性神经疾病中使用干细胞和纳米药物输送可以实现神经保护的未来。